Associate Director, Epidemiology
Johnson & Johnson, United Kingdom
Justin Bohn, ScD is Associate Director of Epidemiology at Janssen Research & Development, a Johnson & Johnson Company. His work focuses on epidemiological research related to therapies in neuroscience, as well as methodological research to identify potential unknown benefits of existing therapies. He holds an ScD in Epidemiology from Harvard T.H. Chan School of Public Health, and has previously served as Senior Principal Biostatistician at Biogen, Pharmacoepidemiologist at Harvard Pilgrim Health Care Institute, and as an ORISE Fellow at the US Food and Drug Administration.
Disclosure information not submitted.
Confounding control in high-throughput studies – principles and applications
Monday, August 26, 2024
10:30 AM – 12:00 PM CEST
Brain-penetrant calcium channel blockers for psychiatric use: revisiting the evidence for benefit
Tuesday, August 27, 2024
2:00 PM – 2:15 PM CEST